Alternative regimens of anti-VEGF therapy for neovascular AMD, variable treatment in particular, have become the de facto clinical practice. Their wide adoption is based on a tacit belief in their ...

Thomas A. Ciulla, MD, MBA, recalls a period during training at Harvard Medical School in which the application of lasers was standard treatment for exudative age-related macular degeneration (AMD), ...

A recent study published in JAMA Network Open reveals that higher levels of exposure to outdoor artificial light at night can increase the risk of incident exudative age-related macular degeneration.

Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone. Recurrent exudation in patients with exudative ...

"It is not necessary to measure the extent, height, or length of the DLS [double layer sign]. It is sufficient to know, however, that when DLS is seen that it’s a key risk factor and that regular ...

Patients with a confirmed diagnosis of OSA were compared to a control group without OSA to assess nonadvanced AMD progression. At 5 years, participants with OSA had a significantly higher risk of both ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) ...

Patients with age-related macular degeneration (AMD) initially may present with distortions in fine visual perception, and disease may be asymptomatic. As the disease develops over time, vision ...

Psoriasis is a systemic inflammatory disease in which lipid dysregulation contributes to cardiovascular disease. Because abnormal lipid deposition in the retina is a hallmark of age-related macular ...